|Articles|January 12, 2023
Phesi Releases Results of Global Analysis of Clinical Trials Conducted in 2021
Analysis shows breast cancer was the most extensively studied disease area in previous year.
Advertisement
Phesi has released the results of its global analysis of all clinical trials conducted in 2021. The data show that breast cancer was the most studied disease area, followed by COVID-19. Overall, oncology had a strong presence in the top five, which also included non-small cell lung cancer, solid tumors, and multiple myeloma.
Read more about the analysis
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
2
ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation
3
ACT Brief: Simplifying Trials Through Selective Safety Data, AI-Driven Site Partnerships, and Biopharma Strategic Pivots
4
AI-Enabled Systems Medicine: From Digital Promise to Clinical Operating Model
5